Jacob van Naarden - 01 Feb 2026 Form 4 Insider Report for ELI LILLY & Co (LLY)

Role
EVP,Pres LLY Oncology&HdCorpBD
Signature
/s/ Jonathan Groff for Jacob Van Naarden, pursuant to authorization on file
Issuer symbol
LLY
Transactions as of
01 Feb 2026
Net transactions value
-$1,980,308
Form type
4
Filing time
03 Feb 2026, 16:31:00 UTC
Previous filing
13 Aug 2025
Next filing
11 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Van Naarden Jacob EVP,Pres LLY Oncology&HdCorpBD LILLY CORPORATE CENTER, INDIANAPOLIS /s/ Jonathan Groff for Jacob Van Naarden, pursuant to authorization on file 03 Feb 2026 0001661254

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LLY Common Stock Options Exercise $0 +4,108 +20% $0.000000 24,670 01 Feb 2026 Direct
transaction LLY Common Stock Tax liability $1,980,308 -1,909 -7.7% $1037.15 22,761 01 Feb 2026 Direct
holding LLY Common Stock 4,342 01 Feb 2026 Van Naarden Family Trust F1
holding LLY Common Stock 4,302 01 Feb 2026 By spouse F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LLY Restricted Stock Unit Options Exercise $0 -4,108 -100% $0.000000 0 01 Feb 2026 Common Stock 4,108 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F2 Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.